The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Polyfect enters due diligence agreement

15 Feb 2010 07:00

RNS Number : 0834H
Ipso Ventures PLC
15 February 2010
 



POLYFECT ENTERS DUE DILIGENCE AGREEMENT

 

IPSO Ventures plc ("IPSO"), the creator of commercial value from technology, is pleased to announce thatits investee company, Polyfect Solutions Limited ("Polyfect"), has entered into a technical due diligence agreement (the "Agreement") with a major US surface coatings company (the "US company").

 

In return for an upfront payment of €45,000, the Agreement grants the US company an exclusive right, for three months, to evaluate certain commercial applications for Polyfect's technology and an option to enter into an exclusive licence for those applications, subject to mutual agreement.

 

Under the Agreement, the US company will evaluate the effectiveness of Polyfect's technology in the production of lower cost and better performing polymer emulsion coatings.

 

Polyfect has made rapid progress over the past 12 months:

 

·; Successfully scaling up its innovative technology, to enable its operation as a simple commercial process;

 

·; Engaging its first customers and generating initial revenues; and 

 

·; Developing significant additional intellectual property.

 

Polyfect's Technology

 

The Polyfect process enables savings and quality improvements to plastics through the highly efficient incorporation of functional fillers. Functional fillers are the materials which are used to change the properties of a plastic, such as making it non-static; creating gas barriers or changing its pigmentation. Conventional processes for incorporating functional fillers in plastics often achieve far from optimal results with a significant proportion of the functional material being poorly dispersed. This necessitates the use of larger quantities of filler to achieve the desired properties of the plastic. The fillers are typically more expensive than the virgin plastic and can also degrade its mechanical properties. Polyfect's technology allows significantly less filler to be used, resulting in both cost savings and quality improvements as well as having a positive environmental benefit.

 

Polyfect's technology has the potential to enable the mass production of:

 

·; Cheaper plastics using smaller quantities of expensive functional fillers;

 

·; Plastics with improved mechanical properties; and

 

·; Novel plastic materials with highly attractive properties.

 

Polyfect will grant licences for various applications of its technology to several operators in the plastics' supply chain for integration into their existing processes. The capital expenditure and running costs of using this technology are low, whilst the potential material cost savings are often high, making it profitable for licensees with a short payback time.

 

Ian Balchin, CEO of Polyfect, said: "Our technology has significant potential in a broad range of plastics applications. The US company is carrying out a very comprehensive evaluation of the use of the Polyfect process across their product range. We are engaging with a number of other multi-national corporations for different applications, who also recognise the potential of the process and wish to be amongst the first to realise its benefits."

 

Simon Hunt, Chairman of IPSO and Polyfect, said: "We are very pleased to have attracted the interest of a major US operator in the emulsions coatings sector. It is a strong endorsement of Polyfect's technology and we look forward to progressing this interest to a satisfactory commercial outcome."

 

Further information, please contact:

 

IPSO Ventures plc: Tel: 020 7921 2990

Simon Hunt, Chairman simon@ipsoventures.com

www.ipsoventures.com

Polyfect Solutions Limited

Ian Balchin, CEO ian.balchin@polyfectsolutions.com

 

Ambrian Partners Limited Tel: 020 7634 4712

Samantha Harrison samantha.harrison@ambrian.com

 

Rawlings Financial PR Limited Tel: 01653 618 016

Catriona Valentine catriona@rawlingsfinancial.co.uk

www.rawlingsfinancial.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRBDGDDDBBBGGD
Date   Source Headline
20th Sep 20211:00 pmRNSUpdate
23rd Aug 20214:30 pmRNSUpdate re: Nominated Adviser
20th Aug 20212:00 pmRNSUpdate re: Nominated Adviser
11th Jun 20217:30 amRNSSuspension - Plutus Powergen plc
11th Jun 20217:00 amRNSProposed Reverse Takeover & Suspension of Trading
19th May 20214:18 pmRNSResult of AGM
22nd Apr 20214:09 pmRNSNotice of AGM
8th Mar 202111:17 amRNSHolding(s) in Company
5th Feb 202111:03 amRNSHalf-year Report
29th Jan 20215:09 pmRNSFinal Results
28th Jan 20217:00 amRNSConvertible loan note
8th Jan 20212:58 pmRNSStatement re share price movement
8th Jan 20217:00 amRNSAppointment of Joint Broker
31st Dec 20201:00 pmRNSTotal Voting Rights
10th Dec 20209:30 amRNSDemerger, Admission of Shares & AIM Rule 15 status
4th Dec 202010:00 amRNSReduction of Capital effective
24th Nov 20205:42 pmRNSReduction of Capital approved by the Court
19th Nov 20206:15 pmRNSPlutus Powergen
6th Nov 202011:00 amRNSFurther re Capital Reorganisation
3rd Nov 202011:59 amRNSResult of General Meeting & Further re Demerger
9th Oct 20204:28 pmRNSProposed demerger, placing, notice of GM & update
29th Jun 20207:00 amRNSNew Website Address
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
3rd Apr 202011:26 amRNSHolding(s) in Company
1st Apr 20207:00 amRNSCorporate Update
29th Jan 20207:00 amRNSInterim Results
27th Jan 202010:24 amRNSHolding(s) in Company
22nd Jan 20207:00 amRNSLoan agreement and related party transaction
10th Jan 202012:50 pmRNSResult of General Meeting
10th Jan 202010:59 amRNSResult of AGM
13th Dec 20197:00 amRNSNotice of GM & AGM
21st Nov 20191:29 pmRNSRequisition of General Meeting
19th Nov 20197:00 amRNSOperational and financial update
13th Nov 20195:05 pmRNSReceipt of purported notice of requisition of GM
12th Nov 20194:04 pmRNSDirector holdings & Update on Director Dealings
31st Oct 20196:38 pmRNSFinal Results
30th Oct 20197:00 amRNSBoard update
25th Oct 201911:28 amRNSStatement on Capacity Market EC ruling
21st Oct 20197:00 amRNSBoard update
3rd Sep 20192:02 pmRNSUpdate re Planning Permission Application
29th Aug 20197:00 amRNSAgreement for Gas Site Funding and Rockpool update
12th Aug 20197:00 amRNSSupport to UK National Grid in latest power crisis
31st Jul 20195:00 pmRNSTotal Voting Rights
31st Jul 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20194:00 pmRNSHolding(s) in Company
24th Jul 20195:23 pmRNSHolding(s) in Company
18th Jul 20196:00 pmRNSUpdate on Issue of Equity
16th Jul 20197:00 amRNSIssue of Equity
27th Jun 20192:01 pmRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.